Abstract
Occasionally a single scientific paper may signal a new era in the study of a disease. The 1965 paper by Willy Gepts was such a signal [1]. The (re)discovery of insulitis provided the impetus for new thoughts about the pathogenesis of insulin-dependent diabetes mellitus (IDDM) and for the emergence of a new research field: immunology of IDDM.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Gepts W (1965) Pathological anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14: 619–633
Gepts W (1983) Role of cellular immunity in the pathogenesis of type 1 diabetes. Curr Probl Clin Biochem 12: 86–99
Gepts W, LeCompte PM (1985). The pathology of type 1 (juvenile) diabetes. In: Volk BW, Arquilla ER (eds) The diabetic pancreas. Plenum, New York, pp 337–365
Junker K, Egeberg J, Kromann H, Nerup J (1977) An autopsy study of the islets of Langerhans in acute-onset juvenile diabetes mellitus. Acta Pathol Microbiol Scand (Sect A) 85: 699–706
Bottazzo GF, Dean BM, McNally JM, MacKay EH, Swift PGF, Gamble DR (1985) In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis. N Engl J Med 313: 353–360
Foulis AK, Farquharson MA (1982) Aberrant expression of HLA-DR antigens by insulin-containing ß-cells in recent-onset Type I diabetes mellitus. Diabetes 35:1215–1224
Sibley RK, Sutherland DER, Goetz F, Michael AF (1985) Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases. Lab Invest 53:132–144
Kolb-Bachofen V, Kolb H (1983) New concept of insulitis and B-islet cell destruction. Diabetes 32 [suppl 1]: 22A
Kolb H, Kantwerk G, Treichel U, Kürner T, Kiesel U, Hoppe T, Kolb-Bachofen V (1986) Prospective analysis of islet lesions in BB rats. Diabetologia 29: 559A
Dean BM, Walker R, Bone AJ, Baird JD, Cooke A (1985) Pre-diabetes in the spontaneously diabetic BB/E rat: lymphocyte subpopulations in the pancreatic infiltrate and expression of rat MHC class II molecules in endocrine cells. Diabetologia 28: 464–466
Nerup J, Andersen OO, Bendixen G, Egeberg J, Poulsen JE (1971) Antipancreatic cellular hypersensitivity in diabetes mellitus. Diabetes 20: 424–427
Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiences. Lancet II: 1279–1282
Lernmark Å, Freedman ZR, Hofman C, Rubinstein AH, Steiner DF, Jackson RL, Winter RJ, Traisman HS (1978) Islet-cell-surface antibodies in juvenile diabetes mellitus. N Engl J Med 299:375–380
Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å (1982) Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298:167–169
MacCuish AC, Irvine WJ (1975) Autoimmunological aspects of diabetes mellitus. Clin Endocrinol Metab 4: 434–471
Maron R, Elias D, de Jongh BM, Braining GJ, van Rood JJ, Shechter Y, Cohen IR (1983) Autoantibodies to the insulin receptor in juvenile onset insulin-dependent diabetes. Nature 303:817–818
Huang S-W, Haedt LH, Rich S, Barbosa J (1981) Prevalence of antibodies to nucleic acids in insulin-dependent diabetics and their relatives. Diabetes 30: 873–874
Irvine WJ, Al-Khateeb SF, DiMario U, Feek CM, Gray RS, Edmond B, Duncan UP (1977) Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics. Clin Exp Immunol 30:16–21
Papadopoulos G, Petersen J, Andersen V, Lernmark Å, Marner B, Nerup J, Binder J (1984) Spontaneous in vitro immunoglobulin secretion at the diagnosis of insulin-dependent diabetes. Acta Endocrinol 105: 521–527
Scott J, Nerup J, Lernmark Å (1985) Immunologic factors in diabetes mellitus. In: Rosse WF (ed) Clinical immunology. Update reviews for physicians. Elsevier, Amsterdam, 53–85
Gorsuch AN, Spencer KM, Lister J, McNally JM, Dean BM, Bottazzo GF, Cudworth AG (1981) Evidence for a long prediabetic period in type 1 (insulin-dependent) diabetes mellitus. Lancet II: 1363–1365
Pujoll-Borell R, Hanafusa T, Cudworth AG, Bottazzo GF (1982) Islet-cell surface antibodies and the natural history of Type 1 (insulin-dependent) diabetes. Diabetologia 23:194A
Baekkeskov S, Braining J, Srikanta S, Mandrup-Poulsen T, de Beaufort C, Eisenbarth G, Nerup J, Lemmark Å (1986) Antibodies to a Mr 64,000 human islet cell protein in the prediabetic period of IDDM patients. Ann NY Acad Sci 475: 415–417
Srikanta S, Ricker T, McCulloch DK, Soeldner JS, Eisenbarth GS, Palmer JP (1986) Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus. Diabetes 35:139–142
Marner B, Agner T, Binder C, Lemmark Å, Nerup J, Mandrup-Poulsen T, Waldorff S (1985) Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients. Diabetologia 28: 875–880
Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D (1980) Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage. Lancet I: 668–672
Srikanta S, Ganda OP, Eisenbarth GS, Soeldner JS (1983) Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for type 1 diabetes mellitus. N Engl J Med 308:322–325
Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS (1985) First-degree relatives of patients with type 1 diabetes mellitus. Islet cell antibodies and abnormal insulin secretion. N Engl J Med 313:461–464
Rittenhouse HG, Oxender DL, Pek S, Ar D (1980) Complement-mediated cytotoxic effects on pancreatic islets with sera from diabetic patients. Diabetes 317–322
Dobersen MJ, Scharff JE, Ginsberg-Fellner F, Notkins AL (1980) Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus. N Engl J Med 303:1493–1498
Sai P, Boitard C, Debray-Sachs M, Pouplard A, Assan R, Hamburger J (1981) Complement-fixing islet cell antibodies from some diabetic patients alter insulin release in vitro. Diabetes 30: 1051–1057
Kanatsuna T, Lemmark Å, Rubinstein AH, Steiner DF (1981) Block in insulin release from column-perifused pancreatic beta-cells induced by islet cell surface antibodies and complement. Diabetes 30: 231–234
Kanatsuna T, Baekkeskov S, Lemmark Å, Ludvigsson J (1983) Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release. Diabetes 32: 520–524
Svenningsen A, Dyrberg T, Gerlin I, Lemmark Å, MacKay P, Rabinovitch A (1983) Inhibition of insulin release after passive transfer of immunoglobulin from insulin-dependent diabetic children to mice. J Clin Endocrinol Metab 57:1301–1304
Spencer KM, Tarn A, Dean BM, Lister J, Bottazzo GF (1984) Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes. Lancet I: 764–766
Srikanta S, Ganda OP, Jackson RA, Brink SJ, Fleischnick E, Yunis E, Alper C, Soeldner JS, Eisenbarth GS (1984) Pre-type 1 (insulin-dependent) diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity. Diabetologia 27: 146–148
Tingle AJ, Lim G, Wright VJ, Dimmick JF, Hunt JA (1979) Transplacental passage of islet cell antibodies in infants of diabetic mothers. Pediatr Res 13:1323–1325
Mandrup-Poulsen T, Nerup J, Stiller CR, Marner B, Bille G, Heinrichs D, Martell R, Dupre J, Keown PA, Jenner MR, Rodger NW, Wolfe B, Graffenried BV, Binder C (1985) Disappearance and reappearance of islet cell cytoplasmic antibodies in cyclosporin-treated insulin-dependent diabetics. Lancet I: 599–602
Feutren G, Papoz L, Assan R, Vialettes B, Karsenty G, Vexiau P, Charbonnel B, Rodier M, Lallemand A, Bach J-F (1986) Cyclosporine A in recent onset type 1 (insulin-dependent) diabetic patients: preliminary analysis of the French randomized trial at 6–9 months. Diabetologia 29: 536A
Charles MA, Suzuki M, Waldeck N, Dodson LE, Slater L, Ong K, Kershnar A, Buckingham B, Golden M (1983) Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. J Immunol 130:1189–1195
Lohmann D, Krug J, Lampeter EF, Bierwolf B, Verlohren H-J (1986) Cell-mediated immune reactions against B cells and defect of suppressor cell activity in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29: 421–425
Boitard C, Debray-Sachs M, Pouplard A, Assan R, Hamburger J (1981) Lymphocytes from diabetics suppress insulin release in vitro. Diabetologia 21: 41–46
Quiniou-Debrie MC, Debray-Sachs M, Dardenne M, Czernichow P, Assan R, Bach JF (1985) Anti-islet cellular and humoral immunity, T-cell subsets, and thymic function in type 1 diabetes. Diabetes 34: 373–379
Boitard C, Chatenoud L-M, Debray-Sachs M (1982) In vitro inhibition of pancreatic B cell function by lymphocytes from diabetics with associated autoimmune diseases: a T cell phenomenon. J Immunol 129: 2529–2531
Negishi K, Waldeck N, Chandy G, Buckingham B, Kershnar A, Fisher L, Gupta S, Charles MA (1986) Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes. Diabetologia 29: 352–357
Weringer EJ, Like AA (1985) Immune attack on pancreatic islet transplants in the spontaneously diabetic Biobreeding/Worcester (BB/W) rat is not MHC restricted. J Immunol 134: 2384–2386
Prowse SJ, Bellgrau D, Lafferty KJ (1986) Islet allografts are destroyed by disease occurrence in the spontaneously diabetic BB rat. Diabetes 35:110–114
Nomikos IN, Prowse SJ, Carotenuto P, Lafferty KJ (1986) Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice. Diabetes 35: 1302–1304
Lanier LL, Phillips JH (1986) Evidence for three types of human cytotoxic lymphocytes. Immunol Today 7:132–134
Yanagi Y, Caccia N, Kronenberg M, Chin B, Roder J, Rohel D, Kiyohara, Lauzon R, Toyonaga B, Rosenthal K, Dennert G, Acha-Orbea H, Hengartner H, Hood L, Mak TW (1985) Gene rearrangement in cells with natural killer activity and expression of the beta-chain of the T-cell antigen receptor. Nature 314: 631–633
Moingeon P, Ythier A, Goubin G, Faure F, Nowill A, Delmon L, Rainaud M, Forestier F, Daffos F, Bohuon C, Hercend T (1986) A unique T-cell receptor complex expressed on human fetal lymphocytes displaying natural-killer-like activity. Nature 323: 638–640
Woda BA, Biron CA (1986) Natural killer cell number and function in the spontaneously diabetic BB/W rat. J Immunol 137:1860–1866
MacKay P, Jacobson J, Rabinovitch A (1986) Spontaneous diabetes mellitus in the BioBreeding/Worcester rat. Evidence in vitro for natural killer cell lysis of islet cells. J Clin Invest 77: 916–924
Like AA, Biron CA, Weringer EJ, Byman K, Sroczynski E, Guberski DL (1986) Prevention of diabetes in Biobreeding/Worcester rats with monoclonal antibodies that recognize T lymphocytes or natural killer cells. J Exp Med 164:1145–1159
Debray-Sachs M, Boitard C, Assan R, Hamburger J (1981) Are “activated” macrophages cytotoxic against normal cells? Transplant Proc 13:1111–1113
Schwitzer RW, Leiter EH, Evans R (1984) Macrophage-mediated cytotoxicity against cultured pancreatic islet cells. Transplantation 37: 539–544
Oschilewski U, Kiesel U, Kolb H (1985) Administration of silica prevents diabetes in BB rats. Diabetes 34:197–199
Nash JR, Everson NW, Wood RFM, Bell PRF (1980) Effect of silica and carrageenan on the survival of islet allografts. Transplantation 29: 206–208
Scala G, Allavena P, Djeu JY, Kasahara T, Ortaldo JR, Herberman RB, Oppenheim JJ (1984) Human large granular lymphocytes are potent producers of interleukin-1. Nature 309: 56–59
Bendtzen K (1985) Lymphokines in inflammation. In: Venge P, Lindbom A (eds) Inflammation — basic mechanisms, tissue injuring principles, and clinical models. Almqvist and Wiksell, Stockholm, pp 187–217
Mandrup-Poulsen T, Bendtzen K, Nielsen JH, Bendixen G, Nerup J (1985) Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40: 424–429
Mandrup-Poulsen T, Bendtzen K, Nerup J, Egeberg J, Nielsen JH (1986) Mechanisms of pancreatic islet cell destruction. Dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy 41: 250–259
Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH (1986) Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29: 63–67
Bendtzen K, Mandrup-Poulsen T, Nerup J, Nielsen JH, Dinarello CA, Svenson M (1986) Cytotoxicity of human pI7 interleukin-1 for pancreatic islets of Langerhans. Science 232: 1545–1547
Bendtzen K, Barington T, Mandrup-Poulsen T, Pedersen JG, Svenson M (1986) Measurement of human IL-1 by LIF induction, pancreatic islet-cell cytotoxicity, and bone resorption. Lymphogne Res 5: S93–S98
Mandrup-Poulsen T, Egeberg J, Nerup J, Bendtzen K, Nielsen JH, Dinarello CA (1987) Ultrastructural study of time-course and cellular specificity of interleukin-1 mediated islet cytotoxicity. Acta Pathol Microbiol Immunol Scand (C) Acta path, microbiol. immunol. scand. Sect C, 95:55–63
Dinarello CA (1984) Interleukin-1. Rev Infect Dis 6: 51–95
Dinarello CA (1984) Interleukin-1 and the acute-phase response. N Engl J Med 311: 1413–1418
Dinarello CA (1986) Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (Cachectin). In: Cruse JM, Lewis RE, Jackson M (eds) The year in immunology, vol 2. Karger, Basel, pp 68–89
Klempner MS, Dinarello CA, Henderson WR, Gallin JI (1979) Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen. J Clin Invest 64: 996–1002
Matsubara T, Ziff M (1986) Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 137: 3295–3298
Malaisse WJ (1982) Alloxan toxicity to the pancreatic B-cell. A new hypothesis. Biochem Pharmacol 31:3527–3534
Svejgaard A, Jakobsen BK, Platz P, Ryder LP, Nerup J, Christy M, Borch-Johnsen K, Parving H-H, Deckert T, Mølsted-Pedersen L, Kühl C, Buschard K, Green A (1986) HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population. Tissue Antigens 28: 237–244
Nerup J (1974) The clinical and immunological association of diabetes mellitus and Addison’s disease. In: Bastenie PA, Gepts W (eds) Immunity and autoimmunity in diabetes mellitus. Excerpta Medica, Amsterdam, pp 149–152
Nerup J, Mandrup-Poulsen T, Molvig J (1987) The HLA-IDDM association: implications for etiology and pathogenesis of IDDM. In: De Fronzo RA, Skylev JS (eds) Diabetes/Metabolism Rev 3: 779–802
Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D, Strominger JL (1986) Genes for the tumor necrosis factors α and ß are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA 83: 8699–8702
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Nerup, J., Mandrup-PouIsen, T., Mølvig, J., Spinas, G. (1988). Immune Interactions with Islet Cells: Implications for the Pathogenesis of Insulin-Dependent Diabetes Mellitus. In: Lefèbvre, P.J., Pipeleers, D.G. (eds) The Pathology of the Endocrine Pancreas in Diabetes. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-72691-0_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-72691-0_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-72693-4
Online ISBN: 978-3-642-72691-0
eBook Packages: Springer Book Archive